The effect of coencapsulation of bovine insulin with cyclodextrins in ethylcellulose microcapsules

References

• Aboubaker M, Puisieux F, Couvreur P, Deyme M, Vauthier C. 1999. Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization. Journal of Biomedical Materials Research 47:568–576.
   PubMedGoogle Scholar
• Agarwal V, Reddy IK, Khan MA. 2001. Polymethyacrylate based microparticulates of insulin for oral delivery: Preparation and in vitro dissolution stability in the presence of enzyme inhibitors. International Journal of Pharmaceutics 225:31–39.
   PubMedGoogle Scholar
• Banga AK, Mitra R. 1993. Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. Journal of Drug Targeting 1:341–345.
   PubMedGoogle Scholar
• Barichello JM, Morishita M, Takayama K, Nagai T. 1999. Encapsulation of hydrophilic and lipophilic drugs in plga nanoparticles by the nanoprecipitation method. Drug Development and Industrial Pharmacy 25:471-476. Brange J, Langkjoer L. 1993. Insulin structure and stability. Pharmaceutical Biotechnology 5:315–350.
   Google Scholar
• Choi SH, Kwon JH, Kim CW. 2004. Microencapsulation of insulin microcrystals. Bioscience, Biotechnology, and Biochemistry 68:749–752.
   PubMedGoogle Scholar
• Cournarie F, Cheron M, Besnard M, Vauthier C. 2004. Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules. European Journal of Pharmaceutics and Biopharmaceutics 57:171–179.
   PubMedGoogle Scholar
• Dzwolak W, Ravindra R, Lendermann J, Winter R. 2003. Aggregation of bovine insulin probed by dsc/ppc calorimetry and ftir spectroscopy. Biochemistry 42:11347–11355.
   PubMedGoogle Scholar
• Goto S, Moriya F, Kawata M, Kimura T. 1984. Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin. Journal of Microencapsulation 1:137–155.
   PubMedGoogle Scholar
• Griaznova NS, Petiushenko RM, Beliavskaia IV, Berezovskaia LN, Zhukov VG, Sviridov BD, Sazykin Iu 0, Navashin SM. 1992. [obtaining liposomal preparations of various biologically active substances by the method of detergent flow analysis] . Antibiotiki i Khimioterapiia 37:3–8.
   Google Scholar
• Jiang G, Qiu W, DeLuca PP. 2003. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-plga composite microspheres. Pharmaceutical Research 20:452–459.
   PubMedGoogle Scholar
• Johnson OL, Tracy MA. 1999. Peptide and protein drug delivery. In: Mathiowitz E, Mathiowitz E, editors. Encyclopedia of controlled drug delivery. New York: Wiley-Interscience. pp 816–833.
   Google Scholar
• Kato Y, Hosokawa T, Hayakawa E, Ito K. 1993. Influence of liposomes on tryptic digestion of insulin. Biological and Pharmaceutical Bulletin 16:457–461.
   PubMedGoogle Scholar
• Khachidze DG, Kalandadze YL, Monaselidze JR. 2001. Microcalorimetric studies of insulin and zn(ii)-insulin over a wide range of ph and protein concentration. Journal of Biological Physics and Chemistry 1:64–67.
   Google Scholar
• Kinnarinen T, Jarho P, Jarvinen K, Jarvinen T. 2003. Pulmonary deposition of a budesonide/gamma-cyclodextrin complex in vitro. Journal of Controlled Release 90:197–205.
   PubMedGoogle Scholar
• Langer R, Moses M. 1991. Biocompatible controlled release polymers for delivery of polypeptides and growth factors. Journal of Cellular Biochemistry 45:340–345.
   PubMedGoogle Scholar
• Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins 1. Drug solubilization and stabilization. Journal of Pharmaceutical Sciences 85:1017–1025.
   Google Scholar
• Lovatt M, Cooper A, Camilleri P. 1996. Energetics of cyclodextrin-induced dissociation of insulin. European Biophysics Journal 24:354–357.
   PubMedGoogle Scholar
• Ma Z, Yeoh HH, Lim LY. 2002. Formulation ph modulates the interaction of insulin with chitosan nanoparticles. Journal of Pharmaceutical Sciences 91:1396–1404.
   PubMedGoogle Scholar
• Machluf M, Orsola A, Atala A. 2000. Controlled release of therapeutic agents: Slow delivery and cell encapsulation. World Journal of Urology 18:80–83.
   PubMedGoogle Scholar
• Mandal TK. 1998. Evaluation of a novel phase separation technique for the encapsulation of water-soluble drugs in biodegradable polymer. Drug Development and Industrial Pharmacy 24:623–629.
   PubMedGoogle Scholar
• Mark Saltzman W, Baldwin SP. 1998. Materials for protein delivery in tissue engineering. Advanced Drug Delivery Reviews 33:71–86.
   PubMedGoogle Scholar
• Onal S, Zihnioglu F. 2002. Encapsulation of insulin in chitosan-coated alginate beads: Oral therapeutic peptide delivery. Artificial Cells, Blood Substitutes and Immobilization Biotechnology 30:229–237.
   PubMedGoogle Scholar
• Pan Y, Li YJ, Gao P, Ding PT, Xu H, Zheng JM. 2003. [Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly (lactic-co-glycolic acid) nanoparticles]. Yao Xue Xue Bao 38:467–470.
   PubMedGoogle Scholar
• Quaglia F, De Rosa G, Granata E, Ungaro F, Fattal E, Immacolata La Rotonda M. 2003. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. Journal of Controlled Release 86:267–278.
   PubMedGoogle Scholar
• Raj NK, Sharma CP. 2003. Oral insulin-a perspective. Journal of Biomaterials Applications 17:183-196. Rajabi-Siahboomi AR. 2003. An overview of current oral modified release technologies. Business Briefing: Pharmatech 2003:181–184.
   Google Scholar
• Rogues M, Damge C, Michel C, Staedel C, Cremel G, Hubert P. 1992. Encapsulation of insulin for oral administration preserves interaction of the hormone with its receptor in vitro. Diabetes 41:451–456.
   PubMedGoogle Scholar
• Rosa GD, Iommelli R, La Rotonda MI, Miro A, Quaglia F. 2000. Influence of the co-encapsulation of different non-ionic surfactants on the properties of plga insulin-loaded microspheres. Journal of Controlled Release 69:283–295.
   PubMedGoogle Scholar
• Shao PG, Bailey LC. 2000. Porcine insulin biodegradable polyester microspheres: Stability and in vitro release characteristics. Pharmaceutical Development and Technology 5:1–9.
   PubMedGoogle Scholar
• Slager J, Domb AJ. 2002. Stereocomplexes based on poly(lactic acid) and insulin: Formulation and release studies. Biomaterials 23:4389–4396.
   PubMedGoogle Scholar
• Spangler RS. 1990. Insulin administration via liposomes. Diabetes Care 13:911–922.
   PubMedGoogle Scholar
• Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharmaceutical Research 14:556–567.
   PubMedGoogle Scholar
• Tokihiro K, Irie T, Uekama K. 1997. Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution. Chemical and Pharmaceutical Bulletin 45:525–531.
   PubMedGoogle Scholar
• Varde NK, Pack DW. 2004. Microspheres for controlled release drug delivery. Expert Opinion on Biological Therapy 4:35–51.
   PubMedGoogle Scholar
• Yamaguchi Y, Takenaga M, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. 2002. Insulin-loaded biodegradable plga microcapsules: Initial burst release controlled by hydrophilic additives. Journal of Controlled Release 81:235–249.
   PubMed Web of Science ®Google Scholar